Colombia vs Dominican Republic: Share of people with HIV who receive antiretroviral therapy
Colombia
66.0%
in 2023
Dominican Republic
66.0%
in 2024
Colombia rank
87th
Dominican Republic rank
87th
Share of people with HIV who receive antiretroviral therapy over time
- Colombia
- Dominican Republic
How they compare
Colombia currently reports 66.0% against 66.0% in Dominican Republic, a difference of 0.0%.
The two have swapped places 3 times across 24 shared years of data; in 2000 it was Dominican Republic ahead.
Colombia ranks 87th and Dominican Republic ranks 87th of 143 countries.
Colombia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.1% | 4.9% | 1.2% | Colombia |
| 2010s | 37.2% | 32.4% | 4.8% | Colombia |
| 2020s | 62.5% | 56.2% | 6.2% | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Colombia or Dominican Republic?
- Colombia, at 66.0% against 66.0% in Dominican Republic as of 2023.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Colombia and Dominican Republic?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Dominican Republic?
- 24 years are reported by both, from 2000 to 2023.
- How do Colombia and Dominican Republic rank globally for share of people with hiv who receive antiretroviral therapy?
- Colombia ranks 87th and Dominican Republic ranks 87th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.